节点文献

转化生长因子β1低密度脂蛋白胆固醇 脂蛋白a在特发性难治性局灶节段性肾小球硬化中表达的意义

Clinical significance of TGF-β1,LDL-C and Lp(a) in focal segmental glomerulosclerosis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 蒋莹辉尚文英支忠继曹西田王欣赵晓镡红印

【Author】 Jiang Yinghui;Shang Wenying;Zhi Zhongji;Cao Xitian;Wang Xin;Zhao Xiao;Shan Hongyin;Section 5,Shijiazhuang Kidney Disease Hospital;

【机构】 石家庄肾病医院肾五科石家庄肾病医院检验科河北医科大学第三医院内分泌科

【摘要】 目的探讨特发性难治性局灶节段性肾小球硬化(FSGS)患者脂蛋白a[Lp(a)]、低密度脂蛋白胆固醇(LDL-C)、转化生长因子β1(TGF-β1)水平与疗效的相关性。方法回顾性分析134例特发性FSGS患者,根据治疗4个月时尿蛋白定量、肾功能及血清白蛋白情况分为难治组64例和激素敏感组70例,分析足量激素治疗前,治疗2、4、6个月时血清胆固醇(CHO)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、LDL-C、Lp(a)和TGF-β1水平。结果特发性FSGS难治组和FSGS激素敏感组的血清Lp(a)、TGF-β1、LDL-C均明显高于正常范围,难治组Lp(a)和TGF-β1高于激素敏感组,差异有统计学意义(P<0.05);难治组LDL-C较激素敏感组升高,但差异无统计学意义(P>0.05)。经足量激素治疗4个月后,激素敏感组Lp(a)、TGF-β1、LDL-C较治疗前均明显下降,差异有统计学意义(P<0.05)。难治组Lp(a)、TGF-β1、LDL-C较治疗前无明显变化,差异无统计学意义(P>0.05)。结论特发性FSGS存在Lp(a)、TGF-β1的代谢紊乱,同时其升高程度可作为特发性难治性FSGS早期判定指标,早期联合其他治疗方案,减少激素不良反应。

【Abstract】 Objective To investigate the relationship between plasma transforming growth factor-β1(TGF-β1),low density lipoprotein cholesterol(LDL-C)and lipoprotein(a)[Lp(a)]in focal segmental glomerulosclerosis(FSGS).Methods A total of 134 patients were enrolled in this cross-sectional study.According to urinary protein,renal function and plasma protein after enough prednisone treatment for 4months,patients were divided into 64 cases as difficulty group and70 cases as sensitive group.Level of TGF-β1,LDL-C and Lp(a)were analyzed before and 2,4,6months after treatment among different groups.Results Level of plasma Lp(a),TGF-β1and LDL-C were higher than normal in both groups.Lp(a)and TGF-β1in difficulty group were higher than those in sensitive group(P<0.05).Level of plasma LDL-C was not significant(P>0.05).After treatment with enough prednisone for 4months,Lp(a),TGF-β1and LDL-C were lower in sensitive group than before(P<0.05).Another group was not significant(P>0.05).Conclusion Level of plasma Lp(a),TGF-β1was disordered in FSGS.They can be used as early marker in difficulty group.

【基金】 石家庄市科学技术研究与发展指导计划(131462303)
  • 【文献出处】 山西医药杂志 ,Shanxi Medical Journal , 编辑部邮箱 ,2014年17期
  • 【分类号】R692.6
  • 【下载频次】51
节点文献中: 

本文链接的文献网络图示:

本文的引文网络